Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Dipraglurant by Addex Therapeutics for Blepharospasm: Likelihood of Approval
Dipraglurant is under clinical development by Addex Therapeutics and currently in Phase II for Blepharospasm. According to GlobalData, Phase II...